GILD Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Gilead Sciences Inc. Stock Analysis GILD
United States Health Care Large Cap Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The firm is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. The company is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Anitocabtagene autoleucel, Sacituzumab govitecan-hziy, and Domvanalimab and zimberelimab. Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. The company operates in more than 35 countries worldwide.
Read More GILD Chart
Gilead Sciences Inc vs S&P 500 Comparative Returns
Analysis of GILD stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Gilead Sciences... (GIL...) 29.93%
- S&P 500 8.2%
Gilead Sciences Inc Outperformed S&P 500 by 21.73%
1Y Performance
- Gilead Sciences... (GIL...) 64.43%
- S&P 500 17.63%
Gilead Sciences Inc Outperformed S&P 500 by 46.80%
3Y Performance
- Gilead Sciences... (GIL...) 90.63%
- S&P 500 54.54%
Gilead Sciences Inc Outperformed S&P 500 by 36.09%
5Y Performance
- Gilead Sciences... (GIL...) 76.03%
- S&P 500 94.73%
Gilead Sciences Inc Underperformed S&P 500 by 18.70%
Key Statistics of Gilead Sciences Inc (GILD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$119.80Volume
4.93MP/E Ratio (TTM)
294.1452 Week Range
Market Cap
137.04BAvg. Volume
6.23MDividend Yield
4.19%Financial Metrics & Statements of Gilead Sciences Inc (GILD)
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 19.69 | 21.77 | 21.88 | 21.76 | - |
EBIT per Share (TTM) | 3.25 | 7.91 | 8.04 | 7.91 | - |
Earnings per Share (EPS) (TTM) | 0.1 | 4.96 | 3.66 | 4.54 | - |
Dividend per Share (TTM) | 2.75 | 2.87 | 2.97 | 3.06 | - |
EPS Forward | - | - | - | 4.5 | 0.38 |
Annual 
Quarterly
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Net Margin | 0.01 | 0.23 | 0.17 | 0.21 | 0.02 |
Quick Ratio | 1.08 | 0.95 | 0.99 | 1.06 | 1.2 |
Current Ratio | 1.4 | 1.27 | 1.29 | 1.43 | 1.6 |
Price to Earnings (TTM) | 0 | 0 | 0 | 0 | 0 |
price_to_earning | 0 | 0 | 0 | 0 | 0 |
Price to Sales (TTM) | 0 | 0 | 0 | 0 | 0 |
Price to Book | 4.01 | 4.32 | 5.07 | 4.42 | 5.96 |
Free Cash Flow Margin | 0.3 | 0.4 | 0.31 | 0.27 | 0.36 |
Payout Ratio (TTM) | 0 | 0 | 0 | 0 | 0 |
Gross Margin | 0.81 | 0.76 | 0.79 | 0.78 | 0.78 |
Return on Equity (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Assets | 0 | 0.09 | 0.07 | 0.09 | 0.01 |
Return on Assets (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Invested Capital | 0 | 0.13 | 0.1 | 0.12 | 0.01 |
Inventory Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Receivables Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Asset Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt to Equity | 1.57 | 1.2 | 1.08 | 1.02 | 1.29 |
Total Debt to Total Asset | 0.46 | 0.39 | 0.4 | 0.4 | 0.45 |
Long-Term Debt to Total Asset | 0.42 | 0.37 | 0.36 | 0.37 | 0.42 |
Total Debt to Total Capital | 0.63 | 0.56 | 0.54 | 0.52 | 0.58 |
Operating Margin | 0.16 | 0.36 | 0.27 | 0.28 | 0.06 |
Price to Earning | 582.6 | 14.64 | 23.46 | 17.84 | - |
Super Investors invested in Gilead Sciences Inc (GILD)
View All ➜Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Dodge & Cox
% Portfolio:
2.09 Recent Activity:-0.77%
John Rogers
% Portfolio:
0.57 Recent Activity:7.66%
Jefferies Group
% Portfolio:
0.51 Recent Activity:20.24%
Joel Greenblatt
% Portfolio:
0.23 Recent Activity:-1.97%
Community-Curated Collections with Gilead Sciences Inc (GILD)
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
shariah list nifty 50
By trading view
2111 Followers
HALAL STOCK of india
By Aasif Khan
1877 Followers
My Halal AI Stocks Technology - 2024
By Doniyor Akhmadjon
661 Followers
Recent Halal Top Performers US
By Doniyor Akhmadjon
441 Followers
Dow Jones Industrial Average Index
By Dilnoza Mirsaidova
236 Followers
Zero Debt Stocks in India
By Javokhir Suyundikov
122 Followers
1st HALAL NIFTY SMALLCAP 250
By Abdul Mannan
110 Followers
Halal stocks in INDIA
By Altaf Khan
109 Followers
IT Sector Stocks in India
By Javokhir Suyundikov
107 Followers
Halal Divident Stock
By Monirul Islam
99 Followers
FAQ's for Gilead Sciences Inc (GILD)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks for Gilead Sciences Inc (GILD)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
